Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
Middle East & Africa clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
MEA clinical trial biorepository & archiving solutions market highlights
- The MEA clinical trial biorepository & archiving solutions market generated a revenue of USD 45.2 million in 2023.
- The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 45.2 million |
| Market revenue in 2030 | USD 85.6 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.1% of the global clinical trial biorepository & archiving solutions market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,211.9 million by 2030.
Biorepository services was the largest segment with a revenue share of 66.37% in 2023. Horizon Databook has segmented the Middle East & Africa clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Middle East & Africa is one of the emerging markets for conducting clinical trials owing to increase in the demand for quality care, presence of a diverse population, and ease in patient recruitment. In addition, this region offers logistic benefits as European pharmaceutical companies are located in proximity to African regions than Latin America.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA clinical trial biorepository & archiving solutions market size, by country, 2018-2030 (US$M)
Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
